Law360
DOJ Kickback Concerns Extend Beyond Federal Funds
April 13, 2022
The federal government has expressed growing interest in pursuing enforcement actions focused on alleged kickbacks in the health care industry that it cannot reach with its tried-and-true lever, the Anti-Kickback Statute.
Specifically, where alleged kickback arrangements do not implicate federal funds, the U.S. Department of Justice increasingly is turning to the Travel Act and the Eliminating Kickbacks in Recovery Act, or EKRA.
Capabilities
Suggested News & Insights
Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026Six Sidley Partners Honored as 2026 “MVPs” by Law360November 2, 2026Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarinOctober 30, 2026U.S. Treasury Proposes Sweeping Limits on U.S. Investments in “Countries of Concern”: Biotechnology, Super Intelligence, and MoreOctober 28, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
